NIKI
Niki BioSolutions, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.08
+2.46%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-5.9%
Return on equity
-7.3%
Return on assets
-6.8%
Return on invested capital
0.00x
Asset turnover
-$1.8M
Cash from operations
$1.18
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025